Krause Megan L, Makol Ashima
Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, MN, USA.
Open Access Rheumatol. 2016 Mar 23;8:23-36. doi: 10.2147/OARRR.S85340. eCollection 2016.
Rheumatoid arthritis, a chronic inflammatory autoimmune disease with significant physical disability, affects women three times more frequently than men, often in their childbearing years. Parenthood decisions can be challenging, often affected by perceptions of their disease state, health care needs, and complex pharmacological treatments. Many women struggle to find adequate information to guide them on pregnancy planning, lactation, and early parenting in relation to their chronic condition. The expanded availability and choice of pharmacotherapies have supported optimal disease control prior to conception and enhanced physical capabilities for women to successfully overcome the challenges of raising children but require a detailed understanding of their risks and safety in the setting of pregnancy and breastfeeding. This review outlines the various situational challenges faced by rheumatologists in providing care to men and women in the reproductive age group interested in starting a family. Up to date evidence-based solutions particularly focusing on the safe use of disease-modifying antirheumatic drugs and biologic response modifiers to assist rheumatologists in the care of pregnant and lactating women with RA are reviewed.
类风湿关节炎是一种导致严重身体残疾的慢性炎症性自身免疫性疾病,女性患者的发病率是男性的三倍,且通常发病于育龄期。生育决策可能具有挑战性,往往受到对自身疾病状况、医疗需求以及复杂药物治疗的认知影响。许多女性难以找到足够的信息来指导她们在患有慢性病的情况下进行妊娠规划、哺乳和早期育儿。药物治疗方法的增加和选择的扩大有助于在受孕前实现最佳疾病控制,并增强女性成功应对养育子女挑战的身体能力,但需要详细了解这些药物在妊娠和哺乳期的风险及安全性。本综述概述了风湿病学家在为有生育意愿的育龄男性和女性提供护理时面临的各种情况挑战。本文还综述了最新的循证解决方案,尤其侧重于安全使用改善病情抗风湿药物和生物反应调节剂,以协助风湿病学家护理患有类风湿关节炎的孕妇和哺乳期妇女。